Clinical trials
Phase 1/2 Lymphoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Active, not recruiting | 4 |
| Completed | 4 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AHS Cancer Control Alberta | 1 |
| Aegera Therapeutics | 1 |
| Allogene Therapeutics | 1 |
| Australian & New Zealand Children's Haematology/Oncology Group | 1 |
| CRISPR Therapeutics AG | 1 |
| Dr. Jean-Sebastien Delisle, MD, PhD | 1 |
| Hoffmann-La Roche | 1 |
| Intensity Therapeutics, Inc. | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Molecular Templates, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 17 |
| Leukemia | 7 |
| Neoplasms | 5 |
| Recurrence | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Lymphoma, B-Cell | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Central Nervous System Neoplasms | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, Large-Cell, Anaplastic | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.